Hospital Medicine Alert – October 1, 2015
October 1, 2015
View Issues
-
Tighter Blood Pressure Control Post-Intracranial Hemorrhage May Decrease Recurrence
Fifty percent of stroke-related morbidity and mortality are related to intracerebral hemorrhage.
-
Optimal Duration of Anticoagulation for Unprovoked Pulmonary Embolism
The PADIS-PE study is a randomized, double-blind trial of adult patients with a first episode of unprovoked PE that seeks to better define the appropriate duration of therapy.
-
Idarucizumab: A Promising New Drug that Reverses the Anticoagulant Effects of Dabigatran
Several new oral anticoagulants are changing the approach to anticoagulation for patients with nonvalvular atrial fibrillation and deep venous thrombosis/pulmonary emboli.
-
Community-acquired Pneumonia Requiring Hospitalization in Adults
An active population-based surveillance of community-acquired pneumonia requiring hospitalization in adults 18 years of age and older was conducted in five hospitals in Chicago and Nashville. -
Serum Chloride Level Predicts Mortality in Acute Heart Failure
The association between serum sodium level and outcomes in acute decompensated heart failure is well-established.
-
Oral Nutritional Supplementation for Hospitalized COPD Patients Pays Off
<>In contrast to many of the other top 10 causes of death in the United States, COPD deaths are increasing, such that COPD is now the third most common cause of death. Although a variety of pharmacologic interventions are available to improve symptoms and decrease exacerbations, none has been shown to reduce mortality.